0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human Adipose Derived Cells in Two- and Three-Dimensional Cultures: Functional Validation of an In Vitro Fat Construct

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Obesity, defined as a body mass index of 30 kg/m 2 or above, has increased considerably in incidence and frequency within the United States and globally. Associated comorbidities including cardiovascular disease, type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease have led to a focus on the mechanisms promoting the prevention and treatment of obesity. Commonly utilized in vitro models employ human or mouse preadipocyte cell lines in a 2-dimensional (2D) format. Due to the structural, biochemical, and biological limitations of these models, increased attention has been placed on “organ on a chip” technologies for a 3-dimensional (3D) culture. Herein, we describe a method employing cryopreserved primary human stromal vascular fraction (SVF) cells and a human blood product-derived biological scaffold to create a 3D adipose depot in vitro. The “fat-on-chip” 3D cultures have been validated relative to 2D cultures based on proliferation, flow cytometry, adipogenic differentiation, confocal microscopy/immunofluorescence, and functional assays (adipokine secretion, glucose uptake, and lipolysis). Thus, the in vitro culture system demonstrates the critical characteristics required for a humanized 3D white adipose tissue (WAT) model.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion.

          When cells of the established preadipose line 3T3-L1 enter a resting state, they accumulate triglyceride and convert to adipose cells. The adipose conversion is brought about by a large increase in the rate of triglyceride synthesis, as measured by the incorporation rate of labeled palmitate, acetate, and glucose. In a resting 3T3 subline which dose not undergo the adipose conversion, the rate of triglyceride synthesis from these precursors is very low, and similar to that of growing 3T3-L1 cells, before their adipose conversion begins. If 3T3-L1 cells incorporate bromodeoxyuridine during growth, triglyceride synthesis does not increase when the cells reach a stationary state, and triglycerides do not accumulate. As would be expected from their known actions on tissue adipose cells, lipogenic and lipolytic hormones and drugs affect the rate of synthesis and accumulation of triglyceride by 3T3-L1 cells, but in contrast to bromodeoxyuridine, these modulating agents do not seem to affect the proportion of cells which undergoes the adipose conversion. Insulin markedly increases the rate of synthesis and accumulation of triglyceride by fatty 3T3-L1 cells, and produces a related increase in cell protein content. Of 20 randomly selected clones isolated from the original 3T3 stock, 19 are able to convert to adipose cells. The probability of such a conversion varies greatly among the different clones, in most cases being much lower than for 3T3-L1; but once the conversion takes place, the adipose cells produced from all of the 19 clones appear similar. The adipose conversion would seem to depend on an on-off switch, which is on with a different probability in different clones. This probability is quasistably inherited by the clonal progeny.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells.

            L Flynn (2010)
            The development of an engineered adipose tissue substitute, capable of supporting reliable, predictable, and complete fat tissue formation, would be of significant value in the fields of plastic and reconstructive surgery. Towards the goal of engineering an optimized microenvironment for adipogenesis, a decellularization strategy was developed for adipose tissue, which yielded 3-D scaffolds with preserved extracellular matrix architecture. A significant volume of scaffolding material could be obtained from a human tissue source that is commonly discarded. Histology, immunohistochemistry, and scanning electron microscopy confirmed the efficacy and reproducibility of the approach, and also indicated that the basement membrane was conserved in the processed matrix, including laminin and collagen type IV. Seeding experiments with human adipose-derived stem cells indicated that the decellularized adipose tissue (DAT) provided an inductive microenvironment for adipogenesis, supporting the expression of the master regulators PPARgamma and CEBPalpha, without the need for exogenous differentiation factors. High levels of adipogenic gene expression and glycerol-3-phosphate dehydrogenase activity were observed in the induced DAT scaffolds, as compared to cells grown in monolayer or cell aggregate culture. The protein data emphasized the importance of the cell donor source in the development of tissue-engineering strategies for large-volume soft tissue regeneration.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Adipose tissue engineering for soft tissue regeneration.

              Current treatment modalities for soft tissue defects caused by various pathologies and trauma include autologous grafting and commercially available fillers. However, these treatment methods present a number of challenges and limitations, such as donor-site morbidity and volume loss over time. As such, improved therapeutic modalities need to be developed. Tissue engineering techniques offer novel solutions to these problems through development of bioactive tissue constructs that can regenerate adipose tissue in both structure and function. Recently, a number of studies have been designed to explore various methods to engineer human adipose tissue. This review will focus on these developments in the area of adipose tissue engineering for soft tissue replacement. The physiology of adipose tissue and current surgical therapies used to replace lost tissue volume, specifically in breast tissue, are introduced, and current biomaterials, cell sources, and tissue culture strategies are discussed. We discuss future areas of study in adipose tissue engineering.
                Bookmark

                Author and article information

                Contributors
                Journal
                Stem Cells Int
                Stem Cells Int
                SCI
                Stem Cells International
                Hindawi
                1687-966X
                1687-9678
                2020
                10 June 2020
                : 2020
                : 4242130
                Affiliations
                1LaCell LLC, New Orleans LA, USA
                2Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans LA, USA
                3Polish Academy of Science, Olsztyn, Poland
                4Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh PA, USA
                5Departments of Biomedical Engineering and Chemical and Biological Engineering, Bioengineering and Biotechnology Center, Tufts University, Medford MA, USA
                6Department of Pharmacology, Xavier University of Louisiana, New Orleans LA, USA
                7Plastic and Reconstructive Surgery, Baton Rouge LA, USA
                8Obatala Sciences Inc., New Orleans LA, USA
                9LSU Department of Plastic Surgery, New Orleans, LA, USA
                10Department of Structural and Cell Biology, Tulane University School of Medicine, New Orleans LA, USA
                11Department of Medicine, Tulane University School of Medicine, New Orleans LA, USA
                12Department of Surgery, Tulane University School of Medicine, New Orleans LA, USA
                Author notes

                Guest Editor: Ali Mobasheri

                Author information
                https://orcid.org/0000-0002-8314-8486
                https://orcid.org/0000-0001-5163-4263
                https://orcid.org/0000-0002-4990-7418
                https://orcid.org/0000-0003-1689-0987
                Article
                10.1155/2020/4242130
                7303735
                32587620
                dc2ab412-dc3b-4bbc-9586-ff8282b0fc8c
                Copyright © 2020 Robert Bender et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 September 2019
                : 20 January 2020
                : 13 March 2020
                Funding
                Funded by: Obatala Sciences Inc
                Funded by: LaCell LLC
                Funded by: Louisiana Board of Regents Enhancement Grant
                Award ID: LEQSF(2013-15)-ENH-TR-18
                Categories
                Research Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article